THANK YOU FOR SUBSCRIBING
Medical Tech Outlook Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
R-One is a robotic platform that helps interventional cardiologists conduct coronary angioplasties more efficiently. The cardiac muscle is revascularized by inserting one or more implants (stents) into the arteries that supply it with blood during this operation.
Philippe Bencteux, President & Founder, Robocath
FREMONT, CA: Robocath, a company that designs, creates, and markets cardiovascular robotic platforms to treat vascular diseases, announced that the first five robotic coronary angioplasties in Belgium were completed successfully. Prof. Stefan Verheye, a well-known and highly experienced interventional cardiologist at Antwerp’s ZNA Middelheim hospital, and his team performed the Percutaneous Coronary Interventions (PCI) on April 8 and 13. In this country, robotic-assisted PCI has never been done before.
R-One is a robotic platform that helps interventional cardiologists conduct coronary angioplasties more efficiently. The cardiac muscle is revascularized by inserting one or more implants (stents) into the arteries that supply it with blood during this operation.
Robocath’s first solution is known as R-One. This robotic platform is programmed to work with pinpoint accuracy and execute precise movements to aid and improve the interventional procedures performed on the patient. With a significant decrease in X-ray exposure, it also provides a safer working climate for doctors and the entire medical staff. These five robotic procedures are part of a clinical trial involving six European hospitals. The study aims to show how robotic use in daily practice can help interventional cardiologists.
Prof. Stefan Verheye, Interventional Cardiologist at ZNA Middelheim, Antwerp, member of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and author of over 170 peer-reviewed papers (mainly investigating new approaches and innovative technologies), said: “I’m honored to be the first user in Belgium of this French vascular robotic solution. I was immediately very impressed by the ease of use of the platform and its level of precision. The robotic arm places the stent even more precisely than with the manual technique, down to a fraction of a millimeter. In addition, it allows us to work in a much safer and more comfortable setting because we are no longer directly in contact with harmful X-rays, which is of great concern to all physicians in this field.”
“It also means that we no longer need to wear our lead apron which can often cause orthopedics injuries. Therefore, I performed five clinical robotic procedures in a comfortably seated position, without any X-ray exposure. This robotic solution is a first step toward a global revolution in interventional cardiology. I have absolutely no doubt that this solution will be widely taken up. I’m delighted to be among the pioneers of this new technological wave in Europe,” added Verheye.
Read Also
